Skipping Your Annual Medication Review Could Cost You More Than You Think — Here Is the Financial and Clinical Evidence

Most Americans would not skip an annual physical or ignore a warning light on their car's dashboard. Yet millions routinely go year after year without ever having their full medication regimen reviewed by a qualified healthcare professional. The consequences of that oversight are not abstract — they show up in emergency room bills, hospitalization costs, worsening chronic conditions, and prescriptions that no longer serve their intended purpose.

At RxConnect Care, we believe that connected, ongoing care is the foundation of better health outcomes. That means more than processing refills efficiently — it means ensuring that every patient's medication regimen is working as hard for them as it should be. Here is a data-driven look at what skipping your annual medication review actually costs, and why the math strongly favors making it a priority.

1. Adverse Drug Reactions Are One of the Costliest — and Most Preventable — Medical Events in the U.S.

Adverse drug reactions (ADRs) account for approximately 1.3 million emergency room visits each year in the United States, according to the Centers for Disease Control and Prevention. The Agency for Healthcare Research and Quality estimates that drug-related complications cost the U.S. healthcare system more than $30 billion annually.

The striking detail buried within these statistics is how many of these events are preventable. Studies consistently show that a significant proportion of ADR-related hospitalizations result from drug-drug interactions, incorrect dosing, or medications that are no longer appropriate for a patient's current health status — all issues that a thorough medication review is specifically designed to catch.

For a patient managing hypertension and type 2 diabetes, for example, an undetected interaction between a newly prescribed diuretic and an existing medication can trigger a dangerous drop in blood pressure or impair kidney function. The cost of a single related hospitalization can easily exceed $10,000 — a figure that dwarfs the cost of an annual review many times over.

2. Medication Non-Adherence Costs the System — and Patients — Billions Each Year

Non-adherence to prescribed medications is estimated to cost the U.S. healthcare system between $100 billion and $300 billion annually, according to research published in Annals of Internal Medicine. Much of that cost is driven by disease progression that could have been slowed or halted with consistent medication use.

An annual medication review directly addresses the root causes of non-adherence. Patients stop taking medications for a variety of reasons: side effects they were not warned about, confusion over complex regimens, cost concerns, or simply forgetting. A structured review creates an opportunity for a pharmacist or care team member to identify these barriers, simplify the regimen where possible, and connect patients with financial assistance programs for high-cost drugs.

Consider a patient with heart failure who quietly stopped taking a diuretic because of inconvenient side effects. Without intervention, that decision may lead to fluid retention, a decline in cardiac function, and ultimately a hospitalization that costs tens of thousands of dollars. An annual review could have surfaced the issue months earlier and prompted an adjustment that kept the patient stable and at home.

3. Polypharmacy Creates a Compounding Financial Burden That Reviews Can Reduce

Patients taking five or more medications — a group that includes a large proportion of Americans over age 65 — face a compounding financial challenge. Each additional drug represents not only its own cost but also an increased risk of interactions that may require additional prescriptions to manage side effects, creating a cascade of spending.

A medication review can identify opportunities to streamline a regimen, eliminate duplicative therapies, and substitute lower-cost alternatives where clinically appropriate. Research published in The American Journal of Managed Care has found that pharmacist-led medication management programs can reduce total drug costs by an average of 10 to 20 percent for patients with complex regimens.

For a patient spending $500 per month on medications, a 15 percent reduction represents $900 in annual savings — before accounting for the downstream costs of complications avoided.

4. Online Pharmacies With Care Team Support Offer Structural Advantages for Long-Term Value

One of the persistent criticisms of online pharmacy services has been that they prioritize transactional convenience over clinical depth — that they are better at shipping pills than at caring for patients. That characterization may have held some truth in the early days of digital pharmacy, but it does not describe the integrated model that platforms like RxConnect Care are built around.

When a pharmacy operates with an embedded care team — including pharmacists, nurse practitioners, and care coordinators — annual medication reviews become a seamless part of the patient relationship rather than a separate appointment to schedule with a separate provider. Patients can complete reviews via telehealth video visits or secure messaging, without taking time off work or arranging transportation.

This accessibility matters enormously for adherence and follow-through. Patients who might skip an in-person pharmacy consultation because of scheduling friction are far more likely to complete a virtual review that fits into their existing routine. Greater participation translates directly into better outcomes and fewer costly medical events.

5. Chronic Condition Management Improves Measurably With Regular Regimen Oversight

The financial case for medication reviews is perhaps most compelling when examined through the lens of specific chronic conditions:

• Diabetes: The American Diabetes Association estimates that the average annual medical cost for a person with diabetes is approximately $16,752 — more than twice the cost for someone without the condition. Pharmacist-led medication management has been shown in multiple studies to improve HbA1c control, reducing the risk of costly complications including kidney disease, vision loss, and lower-limb amputation.

• Heart disease: Medication non-adherence among heart failure patients is associated with a rehospitalization rate of up to 50 percent within six months of discharge. Regular medication reviews that address adherence barriers have been linked to significant reductions in readmission rates.

• Mental health conditions: Patients with depression or anxiety who are not optimally medicated are more likely to use emergency services, miss work, and incur indirect costs that extend well beyond their pharmacy bills.

Making the Annual Review a Non-Negotiable Part of Your Healthcare Routine

The evidence is consistent and clear: a structured annual medication review is not a luxury or an optional service. It is a clinical and financial imperative, particularly for patients managing chronic conditions or taking multiple medications.

If your current pharmacy or care provider does not offer this service — or if the barriers to accessing it feel prohibitive — it may be time to reconsider your options. At RxConnect Care, annual medication reviews are part of how we define what it means to be a pharmacy that genuinely cares for its patients, not just their prescriptions.

Connecting with a care team that knows your full health history, monitors your regimen over time, and reaches out proactively when something needs attention is not just more convenient than the traditional model. According to the data, it is also considerably less expensive.